TYME Technologies Inc. Information
Contact top employees from
TYME Technologies Inc.
Summary
TYME Technologies Inc. is a public company that has been in the industry for 14 years. The company currently specializes in the Biotechnology, Pharmaceuticals areas. The position of the CEO is occupied by Richie Cunningham. Its headquarters is located at Bedminster, New Jersey, USA. The number of employees ranges from 1 to 25. The annual revenue of TYME Technologies Inc. varies between 5.0M and 25M. Total funding of the company - $8.2M. To connect with TYME Technologies Inc. employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
10-50 employees
Specialties
oncology, pancreatic cancer, cancer therapeutics, biochemistry, prostate cancer, Cancer Metabolism-Based Compounds (CMBTs™), SM-88
DMA Code
New York Metropolitan Area
Founded
2011
Estimated Annual Revenue
$5.0M - 25M
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 1979 | Public Company | 250 - 500 | 6.5M | $296.4M | |
| 1994 | Public Company | 200-500 | - | $- | |
| 2011 | - | 100-200 | - | $- |
Employees Turnover 3 quarter 2025
Length of Employment
Employee tenure at TYME Technologies Inc. shows a diverse range of experience levels:
17% for 3–4 years25% for 5–7 years17% for 8–10 years42% have over 11 years of service at TYME Technologies Inc.Contact top employees from
TYME Technologies Inc.
Paul Sturman
Board Of Directors
Giuseppe Del Priore
Chief Medical Officer
Maria Fernandez
Director | Accounting
Michael Demurjian
Chief Operating Officer
John Zucaro
Senior Vice President
Kotaro Ueda
Founder, Creative Director
TYME Technologies
Owner
Jonathan Eckard
Chief Business Officer
Maria Loushin
Director of Patient Affairs
Similar Companies
FAQ
TYME Technologies Inc. operates in the Biotechnology industries. More details can be found on the official website: tymeinc.com.
The headquarters of TYME Technologies Inc. are located in Bedminster, United States.
The current CEO of TYME Technologies Inc. is Richie Cunningham
You can contact TYME Technologies Inc. by phone at 212-461-2315.
TYME Technologies Inc. currently employs 10-50 people.
TYME Technologies Inc.'s revenue is approximately 22M.
Well-known competitors of TYME Technologies Inc. include INOVIO Pharmaceuticals, Inc., Agenus and NexImmune, Inc..
